These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 5442235)

  • 1. Patterns of damage and regeneration in the murine lymphomyeloid complex following single intravenous doses of mustine hydrochloride.
    Sharp JG; Thomas DB
    J Anat; 1970 Mar; 106(Pt 2):408-9. PubMed ID: 5442235
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
    Scheding S; Media JE; Nakeff A
    Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influencing of hematopoiesis by drugs].
    Baudach A
    Z Arztl Fortbild (Jena); 1972 Jul; 66(13):657-9. PubMed ID: 4636964
    [No Abstract]   [Full Text] [Related]  

  • 4. cis-Dichlorodiammineplatinum(II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice.
    Schaeppi U; Heyman IA; Fleischman RW; Rosenkrantz H; Ilievski V; Phelan R; Cooney DA; Davis RD
    Toxicol Appl Pharmacol; 1973 Jun; 25(2):230-41. PubMed ID: 4197634
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of myelopoiesis by conditioned medium from cultured canine thymic cells exposed to estrogen.
    Farris GM; Benjamin SA
    Am J Vet Res; 1993 Aug; 54(8):1366-73. PubMed ID: 8214911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of cyclophosphamide, nitrogen mustard, and total-body irradiation on survival and on white blood cells in rats.
    Host H
    Radiat Res; 1966 Apr; 27(4):638-51. PubMed ID: 5934825
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemosiderosis due to excessive intake of iron. Report of a case.
    Choudhry VP; Verma IC
    Indian J Pediatr; 1971 Jul; 38(282):306-8. PubMed ID: 5139980
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic trials in panmyelopathies].
    Heinicke HJ
    Z Gesamte Inn Med; 1969 Feb; 24(4):121-3. PubMed ID: 5796656
    [No Abstract]   [Full Text] [Related]  

  • 9. Cain's quinolinium (NSC 176319): protection of murine L1210 leukemia cells and bone marrow progenitor cells against mechlorethamine cytotoxicity and its application to combination chemotherapy.
    Naujokaitis SA
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):97-104. PubMed ID: 7313308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
    Green D; Bensely D; Schein P
    Cancer Res; 1994 Feb; 54(3):738-41. PubMed ID: 8306335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant reticulosis after phenylbutazone therapy. Causal relationship or a random coincidence?].
    Lorenz K; Gebert P
    Munch Med Wochenschr; 1968 Oct; 110(40):2283-7. PubMed ID: 5761601
    [No Abstract]   [Full Text] [Related]  

  • 12. Proton magnetic resonance (PMR) spectroscopic determination of mechlorethamine hydrochloride for injection in commercial unit doses.
    Turczan J; Lau-Cam C
    Pharmazie; 1986 Nov; 41(11):775-6. PubMed ID: 3562509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Leukocyte damages due to exposure to lead].
    Sawinsky A; Durszt J; Påsztor G
    Z Gesamte Hyg; 1971 Apr; 17(4):239-40. PubMed ID: 5121505
    [No Abstract]   [Full Text] [Related]  

  • 15. Epithelial architectural destruction is necessary for bone marrow derived cell contribution to regenerating prostate epithelium.
    Palapattu GS; Meeker A; Harris T; Collector MI; Sharkis SJ; DeMarzo AM; Warlick C; Drake CG; Nelson WG
    J Urol; 2006 Aug; 176(2):813-8. PubMed ID: 16813953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphadenopathy due to parenteral iron therapy.
    Solanki SV; Kabrawala VN
    J Indian Med Assoc; 1968 Jul; 51(1):22-3. PubMed ID: 5703843
    [No Abstract]   [Full Text] [Related]  

  • 17. Analyses of very early hemopoietic regeneration after bone marrow transplantation: comparison of intravenous and intrabone marrow routes.
    Li Q; Hisha H; Yasumizu R; Fan TX; Yang GX; Li Q; Cui YZ; Wang XL; Song CY; Okazaki S; Mizokami T; Cui WH; Guo K; Li M; Feng W; Katou J; Ikehara S
    Stem Cells; 2007 May; 25(5):1186-94. PubMed ID: 17322105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Features of hematopoiesis in mice protected from the lethal effect of cytosar by deoxycytidine].
    Belianchikova NI; Bukhman VM; Barkhotkina MF
    Biull Eksp Biol Med; 1981; 91(1):67-9. PubMed ID: 7214011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical safety assessment of recombinant human GM-CSF in rhesus monkeys.
    Robison RL; Myers LA
    Int Rev Exp Pathol; 1993; 34 Pt A():149-72. PubMed ID: 8454412
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow contributes to renal parenchymal turnover and regeneration.
    Poulsom R; Forbes SJ; Hodivala-Dilke K; Ryan E; Wyles S; Navaratnarasah S; Jeffery R; Hunt T; Alison M; Cook T; Pusey C; Wright NA
    J Pathol; 2001 Sep; 195(2):229-35. PubMed ID: 11592103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.